Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease

Respiratory Distress ◽

Distress Syndrome ◽

Hospitalized Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Infection Disease

Faculty Opinions recommendation of Effect of Titrating Positive End-Expiratory Pressure (PEEP) With an Esophageal Pressure-Guided Strategy vs an Empirical High PEEP-Fio2 Strategy on Death and Days Free From Mechanical Ventilation Among Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735110597.793560070 ◽

2019 ◽

Author(s):

Jesús Villar

Keyword(s):

Clinical Trial ◽

Mechanical Ventilation ◽

Respiratory Distress ◽

Distress Syndrome ◽

Esophageal Pressure ◽

High Peep ◽

Faculty Opinions recommendation of Randomized clinical trial of a combination of an inhaled corticosteroid and beta agonist in patients at risk of developing the acute respiratory distress syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727348815.793567309 ◽

2019 ◽

Author(s):

Kathryn Anne Hibbert

Keyword(s):

Clinical Trial ◽

At Risk ◽

Respiratory Distress ◽

Distress Syndrome ◽

Beta Agonist ◽

Inhaled Corticosteroid ◽

Patients At Risk

A multicentre, randomised, double-blind, placebo-controlled trial to evaluate intravenous infusion of salbutamol versus saline for 28-day mortality in patients with acute respiratory distress syndrome

http://isrctn.org/> ◽

10.1186/isrctn38366450 ◽

2013 ◽

Author(s):

Fang Gao

Keyword(s):

Respiratory Distress ◽

Intravenous Infusion ◽

Distress Syndrome ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(21)00440-9 ◽

2021 ◽

Cited By ~ 1

Author(s):

Aurélien Mazeraud ◽

Matthieu Jamme ◽

Rossella Letizia Mancusi ◽

Claire Latroche ◽

Bruno Megarbane ◽

...

Keyword(s):

Respiratory Distress ◽

Distress Syndrome ◽

Intravenous Immunoglobulins ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.731684831.793572537 ◽

2020 ◽

Author(s):

Jeremy Beitler

Keyword(s):

Clinical Trial ◽

Respiratory Distress ◽

Distress Syndrome ◽

Lung Recruitment ◽

Faculty Opinions recommendation of Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.731684831.793545604 ◽

2018 ◽

Author(s):

Jesús Villar

Keyword(s):

Clinical Trial ◽

Respiratory Distress ◽

Distress Syndrome ◽

Lung Recruitment ◽

Faculty Opinions recommendation of Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.731684831.793540988 ◽

2017 ◽

Cited By ~ 1

Author(s):

Stephen P Peters

Keyword(s):

Clinical Trial ◽

Respiratory Distress ◽

Distress Syndrome ◽

Lung Recruitment ◽

One-Year Outcomes in Patients With Acute Respiratory Distress Syndrome Enrolled in a Randomized Clinical Trial of Helmet Versus Facemask Noninvasive Ventilation

Critical Care Medicine ◽

10.1097/ccm.0000000000003124 ◽

2018 ◽

Vol 46 (7) ◽

pp. 1078-1084 ◽

Cited By ~ 8

Author(s):

Bhakti K. Patel ◽

Krysta S. Wolfe ◽

Erica L. MacKenzie ◽

Dhafer Salem ◽

Cheryl L. Esbrook ◽

...

Keyword(s):

Clinical Trial ◽

Respiratory Distress ◽

Noninvasive Ventilation ◽

Distress Syndrome ◽

One Year

Timing of Renal Support and Outcome of Septic Shock and Acute Respiratory Distress Syndrome. A Post Hoc Analysis of the AKIKI Randomized Clinical Trial

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/rccm.201706-1255oc ◽

2018 ◽

Vol 198 (1) ◽

pp. 58-66 ◽

Cited By ~ 26

Author(s):

Stéphane Gaudry ◽

David Hajage ◽

Frédérique Schortgen ◽

Laurent Martin-Lefevre ◽

Charles Verney ◽

...

Keyword(s):

Clinical Trial ◽

Septic Shock ◽

Respiratory Distress ◽

Distress Syndrome ◽

Post Hoc Analysis ◽

Post Hoc ◽

Renal Support

Driving Pressure–limited Strategy for Patients with Acute Respiratory Distress Syndrome. A Pilot Randomized Clinical Trial

Annals of the American Thoracic Society ◽

10.1513/annalsats.201907-506oc ◽

2020 ◽

Vol 17 (5) ◽

pp. 596-604 ◽

Cited By ~ 4

Author(s):

Marcelo Luz Pereira Romano ◽

Israel Silva Maia ◽

Ligia Nasi Laranjeira ◽

Lucas Petri Damiani ◽

Denise de Moraes Paisani ◽

...

Keyword(s):

Clinical Trial ◽

Respiratory Distress ◽

Distress Syndrome ◽

Driving Pressure